BIOG B — Biogaia AB Income Statement
0.000.00%
Last trade - 00:00
- SEK11.63bn
- SEK10.10bn
- SEK1.30bn
- 98
- 25
- 89
- 84
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 768 | 747 | 785 | 1,104 | 1,297 |
Cost of Revenue | |||||
Gross Profit | 564 | 547 | 583 | 802 | 950 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 526 | 519 | 531 | 742 | 853 |
Operating Profit | 243 | 228 | 254 | 361 | 443 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 242 | 228 | 253 | 448 | 469 |
Provision for Income Taxes | |||||
Net Income After Taxes | 187 | 180 | 196 | 374 | 365 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 187 | 180 | 196 | 374 | 365 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 187 | 180 | 196 | 374 | 365 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.16 | 2.01 | 2.08 | 3.74 | 3.65 |
Dividends per Share |